#Hearing #Aging #HearingLoss #Neuroplasticity #Dementia
Age-related hearing loss and cognitive decline are two major risk factors for
dementia, a condition affecting over 55 million people worldwide. Recent studies suggest that hearing loss accelerates cognitive decline by reducing brain stimulation and promoting social isolation. Yet, despite the availability of hearing aids, their adoption remains low, particularly among individuals with
mild cognitive impairment (MCI), an intermediate condition between normal aging and dementia.
One of the main challenges is the
low utilization and irregular use of hearing aids. Only 11% of those who need them actually use them, and adherence is even lower among patients with cognitive impairment. Barriers include lack of awareness, difficulties in adaptation, and insufficient personalized support. However, some studies indicate that regular use of hearing aids could
reduce the risk of cognitive decline by 19% to 48%, highlighting an underutilized intervention.
In this context, this study explores the impact of a
personalized hearing intervention in patients with MCI and untreated hearing loss. The approach involves multiple follow-up sessions, combining
hearing aid fitting with tailored support to improve adherence and optimize communication strategies.
The objective is to determine whether enhanced auditory care promotes the
adoption of hearing aids and potentially slows
cognitive decline, paving the way for new dementia prevention strategies.
Better hearing, better thinking?
A total of
58 participants aged 55 and older, diagnosed with MCI and
untreated hearing loss (defined by an auditory threshold between 25 and 70 dB), were selected and divided into
two groups:- Intervention group: Equipped with hearing aids and provided with four personalized follow-up sessions to encourage use and improve communication strategies.
- Control group: Received general counseling on healthy aging and an audiology referral for their primary care physician.
Patients were followed for
six months, with the following evaluation criteria: feasibility of recruitment, adherence to the program, and daily use of hearing aids.
The study demonstrated that
randomization and adherence to the intervention were feasible and acceptable. After six months,
81% of participants completed follow-up. Among the intervention group,
83% attended at least two sessions, and 75% used their hearing aid daily, compared to only
22% in the control group. The adherence difference between the groups was
+53% in favor of active intervention. Although no significant impact on cognition was observed at six months, these initial findings justify
a larger-scale trial.
Read next: Effects of vitamin and mineral supplementation on cognitive functions
Hearing: a barrier against dementia?
Age-related hearing loss is a recognized risk factor for
cognitive decline and
dementia, particularly in individuals with
mild cognitive impairment (MCI). Despite the availability of hearing aids, adoption remains low due to lack of screening, awareness, and personalized support.
One of the main challenges is
adherence to hearing aids. Only a small percentage of affected individuals use them regularly, limiting their
preventive potential against cognitive decline. Traditional hearing aid fitting strategies are often insufficient for this population, requiring more tailored approaches.
This study examines
the impact of a personalized hearing intervention on acceptance and use of hearing aids in individuals with MCI. The findings suggest that such programs
significantly increase hearing aid adoption, with a much higher daily usage rate than the control group. While direct cognitive benefits remain to be confirmed, the results indicate that
better hearing could play a crucial role in preventing cognitive decline.
This study has some limitations. The six-month follow-up period is too short to assess the
long-term impact on cognition and dementia prevention. Additionally, direct
effects on the brain were not evaluated, requiring further research. The
scalability of the intervention also needs to be assessed, particularly regarding cost and accessibility.
Despite these limitations, the results support integrating hearing screening and tailored support into cognitive impairment management. A larger and longer trial is needed to evaluate the real impact on cognition and dementia risk. In the long run, this approach could become a key tool for healthy aging and slowing cognitive decline.
Read next: Metformin to reduce the risk of dementia
